Insider · CIK 0001683567
Arnold M Baskies
Files at ANIX (Anixa Biosciences Inc). First filing Jan 29, 2025, latest Sep 28, 2026.
Arnold M Baskies files SEC Form 4 as director at ANIX (Anixa Biosciences Inc). Since Jan 29, 2025, Arnold M Baskies has reported 4 open-market buys worth $75k and 0 open-market sells worth $0, the latest filed on Sep 28, 2026.
A track record needs three past buys with six months of prices behind them; Arnold M Baskies has 0, so none is measured yet.
The newest scored trade: bought $14k of ANIX on Sep 24, 2026, filed Sep 28, 2026, scored 30 (weak). In the last 12 months: 2 buys worth $44k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANIX: Anixa Biosciences Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Anixa Biosciences Inc | $14k 5,000 shares | +4% | - | |
| 31Weak | ANIXbuy Anixa Biosciences Inc | $30k 10,000 shares | +8% | +27% from low-42% from high | |
| 30Weak | Anixa Biosciences Inc | $17k 5,000 shares | +4% | +62% from low-13% from high | |
| 30Weak | Anixa Biosciences Inc | $14k 5,000 shares | +4% | - |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +5,000 | $2.76 | $14k | 140,572 | 15 d ago |
| Jul 27, 2026 | ANIX Anixa Biosciences Inc | MOption exercise Common Stock | +6,000 | $3.13 | $19k | 141,000 | Jul 29, 2026 |
| Jul 27, 2026 | ANIX Anixa Biosciences Inc | FTax withholding Common Stock | -5,428 | $3.46 | $19k | 135,572 | Jul 29, 2026 |
| Jul 27, 2026 | ANIX Anixa Biosciences Inc | MOption exercise Employee Stock Option (Right to Buy)derivative | -6,000 | $0.00 | $0 | 0 | Jul 29, 2026 |
| Jan 28, 2026 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +10,000 | $3.04 | $30k | 135,000 | Jan 29, 2026 |
| Jan 5, 2026 | ANIX Anixa Biosciences Inc | AGrant or award Employee Stock Optionderivative | +25,000 | $0.00 | $0 | 25,000 | Jan 6, 2026 |
| Jul 18, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +5,000 | $3.39 | $17k | 125,000 | Jul 21, 2025 |
| Jan 28, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +5,000 | $2.82 | $14k | 120,000 | Jan 29, 2025 |
| Jan 2, 2025 | ANIX Anixa Biosciences Inc | AGrant or award Employee Stock Optionderivative | +25,000 | $0.00 | $0 | 25,000 | Jan 3, 2025 |
Questions about Arnold M Baskies
Answered from the filings on this page, as of the latest one.
Is Arnold M Baskies buying or selling?
In the last 12 months Arnold M Baskies reported 2 open-market buys worth $44k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $14k of ANIX on Sep 24, 2026. Grants, option exercises and tax withholding are not counted.
How did Arnold M Baskies's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Arnold M Baskies has 0.
Where does Arnold M Baskies file Form 4?
Arnold M Baskies has filed Form 4 at ANIX (Anixa Biosciences Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.